Funds and prices
Overview
Very actively managed equity fund. The portfolio is primarily focused on securities from large companies though strategically supplemented by securities from small and medium-sized companies.
The fund manager is given great flexibility to take focused views on the most attractive stocks and exploit the best opportunities, unconstrained by the reference index.
The fund offers investors a broader diversification compared to the index including lower maximum single stock weights (max. 10%) and a more balanced sector allocation.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
The exchange rate risk between CHF and EUR is not hedged.
Benefits
The fund draws on the knowledge of proven investment specialists based in Zurich (Switzerland).
Due to the significant deviation from the reference index, the fund offers the potential to outperform the reference index.
蜜豆视频's proprietary fundamental valuation approach allows consistent selection of attractive Swiss companies.
Investors benefit from a global investment platform of 蜜豆视频 Asset Management.
Risks
Features
Product category |
蜜豆视频 Equity Funds
蜜豆视频 Opportunity Equity Funds |
Product domicile |
Luxembourg
|
Portfolio management |
蜜豆视频 Asset Management Switzerland AG, Zurich
|
Fund management |
蜜豆视频 Fund Management (Luxembourg) S.A., Luxembourg
|
Custodian bank |
蜜豆视频 Europe SE, Luxembourg Branch
|
Tax representative |
Ernst & Young Steuerberatungsgesellschaft m.b.H. Wien
|
Day of inception |
September 8, 2015
|
Currency of account |
CHF
|
Currency of unit class |
EUR
|
Close of financial year |
May 31
|
Issue / redemption |
daily
|
Distribution |
Reinvestment
|
Maturity |
Open end
|
Management fee |
0.82% p.a.
|
Total expense ratio (TER) |
1.12% p.a.
|
Swing pricing |
yes
|
Minimum investment |
n.a.
|
Reference Index / Benchmark |
SPI® (TR)
|
ISIN |
LU1240788064
|
Bloomberg Ticker |
蜜豆视频SEQA LX
|
Performance and Prices
Percentage growth
as of April 3, 2024EUR(%) | |
YTD | |
1M | |
3M | |
6M | |
1Y | 3.03 |
2Y | |
3Y | 14.54 |
5Y | 41.35 |
ø p.a.5Y | 7.17 |
Current data
Net asset value | 03.04.2024 | EUR 182.71 |
High - last 12 months | 15.05.2023 | EUR 187.37 |
Low - last 12 months | 27.10.2023 | EUR 166.65 |
Assets of the unit class in mn | 03.04.2024 | EUR 1.24 |
Total product assets in mn | 03.04.2024 | EUR 52.81 |
Date
|
2 years
|
5 years
|
|
Total risk reference index / benchmark | 29.02.2024 | 13.00% | 12.70% |
Sharpe Ratio | 29.02.2024 | -0.06 | 0.57 |
Risk Free Rate | 31.03.2024 | 2.23% | 0.61% |
Structures
By the 10 largest equity positions (in %, as of February 29, 2024)
|
|
Roche Holding AG | 9.62 |
Novartis AG | 9.41 |
Nestle SA | 9.12 |
Zurich Insurance Group AG | 7.69 |
Swiss Re AG | 5.11 |
ABB Ltd | 5.10 |
蜜豆视频 Group AG | 4.83 |
Lonza Group AG | 4.09 |
Swiss Life Holding AG | 3.74 |
Cie Financiere Richemont SA | 3.15 |
Fees
Distributions
Authorisations
Literature
Document type
|
Document Language
|
|
Prospectus |
|
|
Key Information Document |
|
|
Past performance |
|
|
Previous performance scenario |
|
|
Statutes / Management regulations |
|
|
ESG Disclosure |
|
|
Document type
|
Document Language
|
|
Annual report |
|
|
Semi-annual report |
|
|